Created at Source Raw Value Validated value
June 25, 2024, noon usa

1. known hypersensitivity to tocilizumab or its excipients 2. patient with a life expectancy of less than 6 months. 3. known active infections or other clinical condition that contra-indicate tocilizumab and cannot be treated or solved according to the judgement of the clinician. 4. neutrophils \<500 / mmc 5. platelets \<40.000 / mmc

1. known hypersensitivity to tocilizumab or its excipients 2. patient with a life expectancy of less than 6 months. 3. known active infections or other clinical condition that contra-indicate tocilizumab and cannot be treated or solved according to the judgement of the clinician. 4. neutrophils \<500 / mmc 5. platelets \<40.000 / mmc

Nov. 16, 2021, 6:30 p.m. usa

known hypersensitivity to tocilizumab or its excipients patient with a life expectancy of less than 6 months. known active infections or other clinical condition that contra-indicate tocilizumab and cannot be treated or solved according to the judgement of the clinician. neutrophils <500 / mmc platelets <40.000 / mmc

known hypersensitivity to tocilizumab or its excipients patient with a life expectancy of less than 6 months. known active infections or other clinical condition that contra-indicate tocilizumab and cannot be treated or solved according to the judgement of the clinician. neutrophils <500 / mmc platelets <40.000 / mmc

Oct. 26, 2020, 11:31 p.m. usa

1. known hypersensitivity to tocilizumab or its excipients 2. patient with a life expectancy of less than 6 months. 3. known active infections or other clinical condition that contra-indicate tocilizumab and cannot be treated or solved according to the judgement of the clinician. 4. neutrophils <500 / mmc 5. platelets <40.000 / mmc

1. known hypersensitivity to tocilizumab or its excipients 2. patient with a life expectancy of less than 6 months. 3. known active infections or other clinical condition that contra-indicate tocilizumab and cannot be treated or solved according to the judgement of the clinician. 4. neutrophils <500 / mmc 5. platelets <40.000 / mmc